SCHEMBL21979360

SCHEMBL21979360

CC(C)(C)[Si](C)(C)OCc1cc([N+](=O)[O-])ccc1S(=O)(=O)Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
LMNA P02545 3/20 0.38
ALPL P05186 1/20 0.36
HSD11B1 P28845 1/20 0.36
CYP3A4 P08684 2/20 0.35
PDE2A O00408 1/20 0.35
PDE5A O76074 1/20 0.35
ALOX15 P16050 1/20 0.35
NFKB1 P19838 1/20 0.35
APEX1 P27695 1/20 0.35
PDE4A P27815 1/20 0.35
BLM P54132 1/20 0.35
PDE1B Q01064 1/20 0.35
PMP22 Q01453 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4D Q08499 1/20 0.35
PDE7A Q13946 1/20 0.35
PDE1C Q14123 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21979436 0.84 HSD17B10 (0.45) ALDH1A1MEN1KMT2ALMNAKDM4E
SCHEMBL2103775 0.83 HTT (0.44) ALDH1A1MEN1KMT2ALMNACYP3A4
SCHEMBL21979353 0.82 IDO1 (0.36) ALDH1A1MEN1KMT2ALMNACYP3A4
SCHEMBL17494979 0.82 ALDH1A1 (0.36) ALDH1A1MEN1KMT2ALMNACYP3A4
SCHEMBL21979443 0.81 TXNRD1 (0.38) ALDH1A1MEN1KMT2ALMNAPDE4B
SCHEMBL30189886 0.81 ALDH1A1 (0.48) ALDH1A1MEN1KMT2ALMNAALPL
SCHEMBL30994728 0.79 ALDH1A1 (0.43) ALDH1A1MEN1KMT2AALOX15CYP1A2
SCHEMBL31345017 0.79 S1PR4 (0.40) ALDH1A1KMT2ALMNACYP1A2HIF1A
SCHEMBL22691421 0.79 KMT2A (0.38) ALDH1A1MEN1KMT2ALMNACYP3A4
SCHEMBL29423582 0.79 KMT2A (0.38) ALDH1A1MEN1KMT2ALMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11230550-B2 Macrocyclic HIV-1 protease inhibitors and uses thereof PURDUE RESEARCH FOUNDATION (US) 2022-01-25 US disclosed
US-20200165264-A1 MACROCYCLIC HIV-1 PROTEASE INHIBITORS AND USES THEREOF PURDUE RESEARCH FOUNDATION 2020-05-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200165264-A1 MACROCYCLIC HIV-1 PROTEASE INHIBITORS AND USES THEREOF SERPINB1, CTRL, CTSC ALDH1A1 1134/4885MEN1 2480/4885KMT2A 3815/4885
US-11230550-B2 Macrocyclic HIV-1 protease inhibitors and uses thereof SERPINB1, CTRL, CTSC ALDH1A1 1134/4885MEN1 2480/4885KMT2A 3815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.